Keywords: Bavarian Nordic, Imvamune, Vaccine, US government contract, Small pox. Ph III study

US government adds $32 million to Bavarian Nordic Imvamune contract

Article | 22 May 2012

Print This

Denmark’s Bavarian Nordic (Nasdaq OMX: BAVA) says that the US Department of Health and Human Services has supported ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in